Medicare & Medicaid
Academy of Managed Care Pharmacy advocates changes in CMS Formulary Guidance
Published in Drug Law Weekly, April 11th, 2006
Primary among the Academy's objections is the fact that many of the stipulations outlined in the CMS Draft Guidance are counter to "best practices" normally followed in the private sector. The Academy believes closer adherence to recognized best practices would enhance pharmacy coverage for beneficiaries and achieve greater cost efficiencies for both plan sponsors and CMS. Of key concern is CMS' stipulation that "all or...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2006-04-11)
More Articles from Drug Law Weekly
- American College of Cardiology
Researchers find viable new sources for stem cell transplants to the heart - EntreMed, Inc.
EntreMed's patent covers broad range of indications for 2-methoxyestradiol - Evercare
Evercare launches educational outreach program to answer Medicare Part D questions - Inex Pharmaceuticals Corp.
Inex licenses three targeted chemotherapy products to Hana Biosciences - Information Technology
Verispan's informatics software identifies top 10 drug classes affected by Medicare Part D - Integrated Security Technologies, Inc.
Integrated Security Technologies complete acquisition of oral insulin patent application - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
